Trials / Completed
CompletedNCT06005220
SBD121, a Synbiotic Medical Food for RA Management
A Randomised, Double Blind Placebo-controlled Trial Evaluating the Medical Food Synbiotic SBD121, Versus Placebo for the Clinical Dietary Management of Early Rheumatoid Arthritis.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 143 (actual)
- Sponsor
- Solarea Bio, Inc · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this randomised, double-blind, placebo controlled clinical food trial is to determine if the medical food SBD121 Synbiotic (prebiotic and probiotic) will aid in the dietary management of symptoms of early rheumatoid arthritis (RA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SBD121 | Medical Food |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2023-09-30
- Primary completion
- 2025-10-06
- Completion
- 2025-10-06
- First posted
- 2023-08-22
- Last updated
- 2025-12-18
Locations
22 sites across 4 countries: Australia, Bulgaria, Moldova, New Zealand
Source: ClinicalTrials.gov record NCT06005220. Inclusion in this directory is not an endorsement.